Middleton & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Middleton & Co's ELV Position: Q1 2026 in Review
Middleton & Co held its Elevance Health (ELV) position steady in Q1 2026 at 1,150 shares worth $337K. The position accounts for 0.04% of the portfolio, ranked #132.
Middleton & Co first reported a position in ELV in Q1 2020 and has held it in 25 quarters since. The position peaked at $872K in Q4 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Middleton & Co held 1,150 shares of Elevance Health worth $337K as of Q1 2026.
- Middleton & Co left its Elevance Health share count unchanged in Q1 2026.
- Elevance Health made up 0.04% of Middleton & Co's portfolio in Q1 2026, its #132 holding.
- Middleton & Co first reported a position in Elevance Health in Q1 2020 and has held it in 25 quarters since.
- Middleton & Co's Elevance Health position peaked at $872K in Q4 2022.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.